1. Home
  2. CTNT vs GRDX Comparison

CTNT vs GRDX Comparison

Compare CTNT & GRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheetah Net Supply Chain Service Inc.

CTNT

Cheetah Net Supply Chain Service Inc.

HOLD

Current Price

$2.69

Market Cap

6.4M

Sector

N/A

ML Signal

HOLD

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

N/A

Current Price

$3.26

Market Cap

7.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTNT
GRDX
Founded
2016
N/A
Country
United States
United Kingdom
Employees
N/A
2
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
7.3M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
CTNT
GRDX
Price
$2.69
$3.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
168.3M
111.7K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
57.74
N/A
EPS
N/A
N/A
Revenue
$1,288,536.00
N/A
Revenue This Year
$42.49
N/A
Revenue Next Year
$22.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
182.69
N/A
52 Week Low
$0.02
$1.87
52 Week High
$4.21
$5.30

Technical Indicators

Market Signals
Indicator
CTNT
GRDX
Relative Strength Index (RSI) 64.10 63.43
Support Level $1.48 $2.01
Resistance Level $4.21 $3.65
Average True Range (ATR) 0.34 0.27
MACD 0.19 0.10
Stochastic Oscillator 64.30 72.34

Price Performance

Historical Comparison
CTNT
GRDX

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: